Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07270601
NA

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Sponsor: ContextVision AB

View on ClinicalTrials.gov

Summary

The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a very common condition called metabolic dysfunction-associated steatotic liver disease (MASLD). Current tests, like MRI or biopsy, can be expensive or invasive. If successful, this ultrasound tool could become an easier and more accessible way to monitor liver health - especially for people with obesity, diabetes, high blood pressure, or high cholesterol.

Official title: Development and Diagnostic Evaluation of a Novel Quantifiable Ultrasound Based Multi-parametric Biomarker for Hepatic Steatosis in Patients With Suspected MASLD ( LYNX )

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

110

Start Date

2025-11-17

Completion Date

2026-12-31

Last Updated

2025-12-08

Healthy Volunteers

Yes

Interventions

DEVICE

Verasonics NXT Data Acquisition System

A research ultrasound imaging device to capture raw radiofrequency ultrasound data for the following parameters: * B-mode imaging * Attenuation coefficient * Backscatter coefficient * Speed of sound * Shear wave elastography

DEVICE

Philips EPIQ Elite

A premium ultrasound system with software package to support imaging research studies.

DEVICE

EchoSense FibroScan

A non-invasive ultrasound solution that accurately measures liver stiffness and liver steatosis.

DEVICE

Philips 3T Ingenia Elition

A 3-tesla magnetic resonance imaging (MRI) system

Locations (1)

University of Washington

Seattle, Washington, United States